294 related articles for article (PubMed ID: 24275940)
1. Dual effects of ketamine: neurotoxicity versus neuroprotection in anesthesia for the developing brain.
Yan J; Jiang H
J Neurosurg Anesthesiol; 2014 Apr; 26(2):155-60. PubMed ID: 24275940
[TBL] [Abstract][Full Text] [Related]
2. Effects of ketamine on the developing central nervous system.
Vutskits L; Gascon E; Kiss JZ
Ideggyogy Sz; 2007 Mar; 60(3-4):109-12. PubMed ID: 17451049
[TBL] [Abstract][Full Text] [Related]
3. Strategies and experimental models for evaluating anesthetics: effects on the developing nervous system.
Wang C; Slikker W
Anesth Analg; 2008 Jun; 106(6):1643-58. PubMed ID: 18499593
[TBL] [Abstract][Full Text] [Related]
4. Relationship between ketamine-induced developmental neurotoxicity and NMDA receptor-mediated calcium influx in neural stem cell-derived neurons.
Wang C; Liu F; Patterson TA; Paule MG; Slikker W
Neurotoxicology; 2017 May; 60():254-259. PubMed ID: 27132109
[TBL] [Abstract][Full Text] [Related]
5. Ketamine: a controversial drug for neonates.
Bhutta AT
Semin Perinatol; 2007 Oct; 31(5):303-8. PubMed ID: 17905185
[TBL] [Abstract][Full Text] [Related]
6. Ketamine-induced neuronal cell death in the perinatal rhesus monkey.
Slikker W; Zou X; Hotchkiss CE; Divine RL; Sadovova N; Twaddle NC; Doerge DR; Scallet AC; Patterson TA; Hanig JP; Paule MG; Wang C
Toxicol Sci; 2007 Jul; 98(1):145-58. PubMed ID: 17426105
[TBL] [Abstract][Full Text] [Related]
7. Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways.
Chizh BA
J Psychopharmacol; 2007 May; 21(3):259-71. PubMed ID: 17591654
[TBL] [Abstract][Full Text] [Related]
8. [Ketamine as an NMDA receptor antagonist].
Kushikata T; Hirota K
Masui; 2013 Jan; 62(1):38-43. PubMed ID: 23431892
[TBL] [Abstract][Full Text] [Related]
9. [NMDA receptor antagonist neurotoxicity and psychotomimetic activity].
Nakao S; Nagata A; Masuzawa M; Miyamoto E; Yamada M; Nishizawa N; Shingu K
Masui; 2003 Jun; 52(6):594-602. PubMed ID: 12854473
[TBL] [Abstract][Full Text] [Related]
10. Protective use of N-methyl-D-aspartate receptor antagonists as a spinoplegia against excitatory amino acid neurotoxicity.
Cho Y; Ueda T; Mori A; Shimizu H; Haga Y; Yozu R
J Vasc Surg; 2005 Oct; 42(4):765-71. PubMed ID: 16242566
[TBL] [Abstract][Full Text] [Related]
11. The vasodilatory effect of ketamine is independent of the N-methyl-D-aspartate receptor: lack of functional N-methyl-D-aspartate receptors in rat mesenteric artery smooth muscle.
Noh HJ; Bae YM; Park SH; Kim JG; Kim B; Kim YS; Kim SH; Cho SI; Woo NS
Eur J Anaesthesiol; 2009 Aug; 26(8):676-82. PubMed ID: 19352184
[TBL] [Abstract][Full Text] [Related]
12. Ketamine-A Narrative Review of Its Uses in Medicine.
Radvansky BM; Puri S; Sifonios AN; Eloy JD; Le V
Am J Ther; 2016; 23(6):e1414-e1426. PubMed ID: 25923225
[TBL] [Abstract][Full Text] [Related]
13. The NMDA antagonist model for schizophrenia: promise and pitfalls.
Abi-Saab WM; D'Souza DC; Moghaddam B; Krystal JH
Pharmacopsychiatry; 1998 Jul; 31 Suppl 2():104-9. PubMed ID: 9754841
[TBL] [Abstract][Full Text] [Related]
14. A comparative evaluation of the neurotoxic properties of ketamine and nitrous oxide.
Jevtovic-Todorovic V; Wozniak DF; Benshoff ND; Olney JW
Brain Res; 2001 Mar; 895(1-2):264-7. PubMed ID: 11259788
[TBL] [Abstract][Full Text] [Related]
15. Ketamine*.
Quibell R; Prommer EE; Mihalyo M; Twycross R; Wilcock A
J Pain Symptom Manage; 2011 Mar; 41(3):640-9. PubMed ID: 21419322
[No Abstract] [Full Text] [Related]
16. Anesthetic neurotoxicity in newborns: should we change clinical practice?
Anand KJ
Anesthesiology; 2007 Jul; 107(1):2-4. PubMed ID: 17585205
[No Abstract] [Full Text] [Related]
17. Effects of NMDA receptor antagonists on visceromotor reflexes and on intestinal motility, in vivo.
Shafton AD; Bogeski G; Kitchener PD; Sanger GJ; Furness JB; Shimizu Y
Neurogastroenterol Motil; 2007 Jul; 19(7):617-24. PubMed ID: 17539896
[TBL] [Abstract][Full Text] [Related]
18. Use of anesthetic agents in neonates and young children.
Mellon RD; Simone AF; Rappaport BA
Anesth Analg; 2007 Mar; 104(3):509-20. PubMed ID: 17312200
[TBL] [Abstract][Full Text] [Related]
19. Comment on "Ketamine has equal affinity for NMDA receptors and the high-affinity state of the dopamine D(2) receptor".
Krystal JH; D'Souza DC
Biol Psychiatry; 2001 Oct; 50(7):555-6. PubMed ID: 11600110
[No Abstract] [Full Text] [Related]
20. Mutual enhancement of central neurotoxicity induced by ketamine followed by methamphetamine.
Ke JJ; Chen HI; Jen CJ; Kuo YM; Cherng CG; Tsai YP; Ho MC; Tsai CW; Yu L
Toxicol Appl Pharmacol; 2008 Mar; 227(2):239-47. PubMed ID: 18076959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
